CD47 and small cell lung carcinoma: As a single-agent treatment, CD47-blocking antibody had minimal effects on the growth of tumors (Fig. 1a), possibly due to cross-reactivity to CD47 expressed on red blood cells and other cells in the body, with fewer molecules of antibody being able to bind to mouse SCLC cells21.